Angiodynamics Inc
ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31
Reports and events: 312 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0812:56 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001628280-26-065423 |
| 2026-10-0808:16 ET | DEF 14A | Proxy statementPeriod 2026-11-17 | 0001140361-26-039022 |
| 2026-10-0807:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-039020 |
| 2026-10-0807:16 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-039019 |
| 2026-09-2916:01 ET | 10-K/A | Annual report, amendedPeriod 2026-05-31 | 0001140361-26-037995 |
| 2026-09-2909:14 ET | 10-K/A | Annual report, amendedPeriod 2026-05-31 | 0001140361-26-037943 |
| 2026-07-1415:42 ET | 10-K | Annual reportPeriod 2026-05-31 | 0001628280-26-048138 |
| 2026-07-1407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028368 |
| 2026-04-2316:59 ET | 8-K | 8.01 Other events | 0001140361-26-016424 |
| 2026-04-0213:56 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001628280-26-023008 |
| 2026-04-0207:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-012891 |
| 2026-02-0317:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-003518 |
| 2026-01-1407:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-001154 |
| 2026-01-0615:19 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001275187-26-000003 |
| 2026-01-0607:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000341 |
| 2025-11-1207:01 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-041542 |
| 2025-10-0216:07 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001628280-25-043689 |
| 2025-10-0207:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-037060 |
| 2025-09-2509:18 ET | DEF 14A | Proxy statementPeriod 2025-05-31 | 0001628280-25-042704 |
| 2025-07-1810:38 ET | 10-K | Annual reportPeriod 2025-05-31 | 0001275187-25-000014 |
| 2025-07-1507:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-025835 |
| 2025-05-2816:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-020621 |
| 2025-04-0214:14 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001275187-25-000010 |
| 2025-04-0209:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011779 |
| 2025-04-0207:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011767 |
| 2025-01-1616:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001285 |
| 2025-01-0814:07 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0001275187-25-000005 |
| 2025-01-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000538 |
| 2025-01-0807:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000535 |
| 2024-11-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-047071 |
| 2024-10-0317:08 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0001628280-24-042176 |
| 2024-10-0307:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-042652 |
| 2024-09-2614:57 ET | DEF 14A | Proxy statementPeriod 2024-05-31 | 0001628280-24-041344 |
| 2024-07-2516:13 ET | 10-K | Annual reportPeriod 2024-05-31 | 0001628280-24-032989 |
| 2024-07-1607:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-033242 |
| 2024-07-1607:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-033240 |
| 2024-04-0917:08 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001628280-24-015487 |
| 2024-04-0407:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-017807 |
| 2024-04-0117:15 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-24-016977 |
| 2024-02-1316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-007427 |
| 2024-01-2207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-002997 |
| 2024-01-1107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001849 |
| 2024-01-0816:47 ET | 10-Q | Quarterly reportPeriod 2023-11-30 | 0001628280-24-000857 |
| 2024-01-0507:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-000830 |
| 2023-11-1620:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-23-053522 |
| 2023-10-0517:15 ET | 10-Q | Quarterly reportPeriod 2023-08-31 | 0001628280-23-033979 |
| 2023-10-0407:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-046804 |
| 2023-09-2815:10 ET | DEF 14A | Proxy statementPeriod 2023-05-31 | 0001628280-23-033186 |
| 2023-08-0317:16 ET | 10-K | Annual reportPeriod 2023-05-31 | 0001628280-23-027335 |
| 2023-07-2416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-035863 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:03 ET. Listed shows no prices and gives no investment advice.